ReviewCurrent vascular pharmacology2024

Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk.

Debabrata Mukherjee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.